ALK and non-small cell lung carcinoma: Therefore, future research should concentrate on elucidating the role of ALK in NSCLC, investigating how its glycosylation and cleavage intricately contribute to treatment resistance, which is pivotal for advancing effective therapeutic interventions in NSCLC patients relying on ALK-targeted therapy [54].